Literature DB >> 25641816

Conjugation of palmitic acid improves potency and longevity of siRNA delivered via endosomolytic polymer nanoparticles.

Samantha M Sarett1, Kameron V Kilchrist1, Martina Miteva1, Craig L Duvall1.   

Abstract

Clinical translation of siRNA therapeutics has beenpan> limited by the inpan>ability to effectively overcome the rigorous delivery barriers associated with inpan>tracellular-actinpan>g biologics. Here, to address both potenpan>cy anpan>d lonpan>gevity of siRpan> class="Chemical">NA gene silencing, pH-responsive micellar nanoparticle (NP) carriers loaded with siRNA conjugated to pan class="Chemical">palmitic acid (siRNA-PA) were investigated as a combined approach to improve siRNA endosomal escape and stability. Conjugation to hydrophobic PA improved NP loading efficiency relative to unmodified siRNA, enabling complete packaging of siRNA-PA at a lower n>n class="Chemical">polymer:siRNA ratio. PA conjugation also increased intracellular uptake of the nucleic acid cargo by 35-fold and produced a 3.1-fold increase in intracellular half-life. The higher uptake and improved retention of siRNA-PA NPs correlated to a 2- and 11-fold decrease in gene silencing IC50 in comparison to siRNA NPs in fibroblasts and mesenchymal stem cells, respectively, for both the model gene luciferase and the therapeutically relevant gene prolyl hydroxylase domain protein 2 (PHD2) . PA conjugation also significantly increased longevity of silencing activity following a single treatment in fibroblasts. Thus, conjugation of PA to siRNA paired with endosomolytic NPs is a promising approach to enhance the functional efficacy of siRNA in tissue regenerative and other applications.
Copyright © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  endosomolytic nanoparticle; gene knockdown; siRNA conjugation

Mesh:

Substances:

Year:  2015        PMID: 25641816      PMCID: PMC4520743          DOI: 10.1002/jbm.a.35413

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  39 in total

1.  Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.

Authors:  Jerome Gilleron; William Querbes; Anja Zeigerer; Anna Borodovsky; Giovanni Marsico; Undine Schubert; Kevin Manygoats; Sarah Seifert; Cordula Andree; Martin Stöter; Hila Epstein-Barash; Ligang Zhang; Victor Koteliansky; Kevin Fitzgerald; Eugenio Fava; Marc Bickle; Yannis Kalaidzidis; Akin Akinc; Martin Maier; Marino Zerial
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

2.  Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus.

Authors:  Meghan J Reilly; John D Larsen; Millicent O Sullivan
Journal:  Mol Pharm       Date:  2012-03-27       Impact factor: 4.939

3.  Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation.

Authors:  Stephany Y Tzeng; Ben P Hung; Warren L Grayson; Jordan J Green
Journal:  Biomaterials       Date:  2012-08-04       Impact factor: 12.479

4.  Controlling mesenchymal stem cell gene expression using polymer-mediated delivery of siRNA.

Authors:  Danielle S W Benoit; Molly E Boutin
Journal:  Biomacromolecules       Date:  2012-10-11       Impact factor: 6.988

Review 5.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

6.  Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.

Authors:  Takanori Kubo; Kazuyoshi Yanagihara; Yoshifumi Takei; Keichiro Mihara; Yuichiro Sato; Toshio Seyama
Journal:  Mol Pharm       Date:  2012-04-24       Impact factor: 4.939

7.  Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.

Authors:  Brian C Evans; Christopher E Nelson; Shann S Yu; Kelsey R Beavers; Arnold J Kim; Hongmei Li; Heather M Nelson; Todd D Giorgio; Craig L Duvall
Journal:  J Vis Exp       Date:  2013-03-09       Impact factor: 1.355

8.  Dual responsive, stabilized nanoparticles for efficient in vivo plasmid delivery.

Authors:  Hua Wei; Lisa R Volpatti; Drew L Sellers; Don O Maris; Ian W Andrews; Ashton S Hemphill; Leslie W Chan; David S H Chu; Philip J Horner; Suzie H Pun
Journal:  Angew Chem Int Ed Engl       Date:  2013-04-16       Impact factor: 15.336

9.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

10.  Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles.

Authors:  Tomoko Nakayama; James S Butler; Alfica Sehgal; Mariano Severgnini; Tim Racie; Jennifer Sharman; Feng Ding; Svetlana Shulga Morskaya; Joshua Brodsky; Lubomir Tchangov; Verbena Kosovrasti; Mike Meys; Lubomir Nechev; Gang Wang; Chang Geng Peng; Yupang Fang; Martin Maier; Kallanthottathil G Rajeev; Robert Li; Julia Hettinger; Scott Barros; Valerie Clausen; Xuemei Zhang; Qianfan Wang; Renta Hutabarat; Nikolay V Dokholyan; Christian Wolfrum; Muthiah Manoharan; Victor Kotelianski; Markus Stoffel; Dinah Wy Sah
Journal:  Mol Ther       Date:  2012-06-05       Impact factor: 11.454

View more
  11 in total

Review 1.  Lipid-Drug Conjugate for Enhancing Drug Delivery.

Authors:  Danielle Irby; Chengan Du; Feng Li
Journal:  Mol Pharm       Date:  2017-01-24       Impact factor: 4.939

2.  Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.

Authors:  Kameron V Kilchrist; Somtochukwu C Dimobi; Meredith A Jackson; Brian C Evans; Thomas A Werfel; Eric A Dailing; Sean K Bedingfield; Isom B Kelly; Craig L Duvall
Journal:  ACS Nano       Date:  2019-01-18       Impact factor: 15.881

3.  Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.

Authors:  Samantha M Sarett; Thomas A Werfel; Linus Lee; Meredith A Jackson; Kameron V Kilchrist; Dana Brantley-Sieders; Craig L Duvall
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 4.  Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.

Authors:  Leo L Wang; Jason A Burdick
Journal:  Adv Healthc Mater       Date:  2016-12-15       Impact factor: 9.933

5.  Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.

Authors:  Samantha M Sarett; Thomas A Werfel; Irene Chandra; Meredith A Jackson; Taylor E Kavanaugh; Madison E Hattaway; Todd D Giorgio; Craig L Duvall
Journal:  Biomaterials       Date:  2016-04-21       Impact factor: 12.479

6.  Local Delivery of PHD2 siRNA from ROS-Degradable Scaffolds to Promote Diabetic Wound Healing.

Authors:  John R Martin; Christopher E Nelson; Mukesh K Gupta; Fang Yu; Samantha M Sarett; Kyle M Hocking; Alonda C Pollins; Lillian B Nanney; Jeffrey M Davidson; Scott A Guelcher; Craig L Duvall
Journal:  Adv Healthc Mater       Date:  2016-09-26       Impact factor: 9.933

Review 7.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

Review 8.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

9.  Hydrogel microspheres for spatiotemporally controlled delivery of RNA and silencing gene expression within scaffold-free tissue engineered constructs.

Authors:  Alexandra McMillan; Minh Khanh Nguyen; Cong Truc Huynh; Samantha M Sarett; Peilin Ge; Melanie Chetverikova; Kien Nguyen; David Grosh; Craig L Duvall; Eben Alsberg
Journal:  Acta Biomater       Date:  2021-01-16       Impact factor: 8.947

Review 10.  Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.

Authors:  Adam G Berger; Jonathan J Chou; Paula T Hammond
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-07-07       Impact factor: 4.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.